DNDi launches neglected disease compound challenge
This article was originally published in Scrip
Executive Summary
The Drugs for Neglected Disease initiative (DNDi) is challenging scientists to find potential targets for drugs to treat African sleeping sickness, visceral leishmaniasis, cutaneous leishmaniasis and Chagas disease.